These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 16388405)

  • 1. Magnetically responsive polymeric microparticles for oral delivery of protein drugs.
    Cheng J; Teply BA; Jeong SY; Yim CH; Ho D; Sherifi I; Jon S; Farokhzad OC; Khademhosseini A; Langer RS
    Pharm Res; 2006 Mar; 23(3):557-64. PubMed ID: 16388405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folate-decorated PLGA nanoparticles as a rationally designed vehicle for the oral delivery of insulin.
    Jain S; Rathi VV; Jain AK; Das M; Godugu C
    Nanomedicine (Lond); 2012 Sep; 7(9):1311-37. PubMed ID: 22583576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of PLGA hydrophilia on the drug release and the hypoglucemic activity of different insulin-loaded PLGA microspheres.
    Presmanes C; de Miguel L; Espada R; Alvarez C; Morales E; Torrado JJ
    J Microencapsul; 2011; 28(8):791-8. PubMed ID: 21967461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dextran-b-poly(lactide-co-glycolide) polymersome for oral delivery of insulin: In vitro and in vivo evaluation.
    Alibolandi M; Alabdollah F; Sadeghi F; Mohammadi M; Abnous K; Ramezani M; Hadizadeh F
    J Control Release; 2016 Apr; 227():58-70. PubMed ID: 26907831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of charge-coupled polymeric microparticles and micromagnets for modulating the bioavailability of orally delivered macromolecules.
    Teply BA; Tong R; Jeong SY; Luther G; Sherifi I; Yim CH; Khademhosseini A; Farokhzad OC; Langer RS; Cheng J
    Biomaterials; 2008 Mar; 29(9):1216-23. PubMed ID: 18082254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of parenteral depot insulin formulation using PLGA and PLA microparticles.
    Naha PC; Kanchan V; Panda AK
    J Biomater Appl; 2009 Nov; 24(4):309-25. PubMed ID: 18987018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs.
    Ungaro F; d'Emmanuele di Villa Bianca R; Giovino C; Miro A; Sorrentino R; Quaglia F; La Rotonda MI
    J Control Release; 2009 Apr; 135(1):25-34. PubMed ID: 19154761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved bioavailability of orally delivered insulin using Eudragit-L30D coated PLGA microparticles.
    Naha PC; Kanchan V; Manna PK; Panda AK
    J Microencapsul; 2008 Jun; 25(4):248-56. PubMed ID: 18465311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption.
    Sheng J; Han L; Qin J; Ru G; Li R; Wu L; Cui D; Yang P; He Y; Wang J
    ACS Appl Mater Interfaces; 2015 Jul; 7(28):15430-41. PubMed ID: 26111015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-S.O (sodium oleate) complex-loaded PLGA nanoparticles: formulation, characterization and in vivo evaluation.
    Sun S; Liang N; Piao H; Yamamoto H; Kawashima Y; Cui F
    J Microencapsul; 2010; 27(6):471-8. PubMed ID: 20113168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subconjunctivally administered celecoxib-PLGA microparticles sustain retinal drug levels and alleviate diabetes-induced oxidative stress in a rat model.
    Ayalasomayajula SP; Kompella UB
    Eur J Pharmacol; 2005 Mar; 511(2-3):191-8. PubMed ID: 15792788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation of budesonide-loaded porous PLGA microparticles and their therapeutic efficacy in a murine asthma model.
    Oh YJ; Lee J; Seo JY; Rhim T; Kim SH; Yoon HJ; Lee KY
    J Control Release; 2011 Feb; 150(1):56-62. PubMed ID: 21070826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small-molecule release from poly(D,L-lactide)/poly(D,L-lactide-co-glycolide) composite microparticles.
    Pollauf EJ; Kim KK; Pack DW
    J Pharm Sci; 2005 Sep; 94(9):2013-22. PubMed ID: 16052542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-arm histidine copolymer for controlled release of insulin from poly(lactide-co-glycolide) microsphere.
    Park W; Kim D; Kang HC; Bae YH; Na K
    Biomaterials; 2012 Dec; 33(34):8848-57. PubMed ID: 22959184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation of preformed porous PLGA microparticles and antisense oligonucleotides loading.
    Ahmed AR; Bodmeier R
    Eur J Pharm Biopharm; 2009 Feb; 71(2):264-70. PubMed ID: 18840521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro study of anticancer drug doxorubicin in PLGA-based microparticles.
    Lin R; Shi Ng L; Wang CH
    Biomaterials; 2005 Jul; 26(21):4476-85. PubMed ID: 15701377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HP55-coated capsule containing PLGA/RS nanoparticles for oral delivery of insulin.
    Wu ZM; Zhou L; Guo XD; Jiang W; Ling L; Qian Y; Luo KQ; Zhang LJ
    Int J Pharm; 2012 Apr; 425(1-2):1-8. PubMed ID: 22248666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and evaluation of alginate-chitosan microspheres for oral delivery of insulin.
    Zhang Y; Wei W; Lv P; Wang L; Ma G
    Eur J Pharm Biopharm; 2011 Jan; 77(1):11-9. PubMed ID: 20933083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Water-soluble betamethasone-loaded poly(lactide-co-glycolide) hollow microparticles as a sustained release dosage form.
    Chaw CS; Yang YY; Lim IJ; Phan TT
    J Microencapsul; 2003; 20(3):349-59. PubMed ID: 12881115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives.
    Mundargi RC; Babu VR; Rangaswamy V; Patel P; Aminabhavi TM
    J Control Release; 2008 Feb; 125(3):193-209. PubMed ID: 18083265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.